Focused Issue on GI Malignancies and Immunotherapy

Posted On 2019-06-25 15:50:52


This focused issue on “GI malignancies and Immunotherapy” is edited by Dr. Khaldoun Almhanna, from Department of Hematology/Oncology, Lifespan Cancer Institute, Providence, RI, USA.

Dr. Khaldoun Almhanna is a gastrointestinal oncologist at the Lifespan Cancer Institute, specializing in hematology and oncology. Dr. Almhanna earned his medical degree from Damascus University in Syria and a master of public health degree from Case Western Reserve University in Cleveland. His research interests include esophageal cancer and gastrointestinal malignancies.

Focused issue outline:
  1. Preface: GI malignancies and immunotherapy
    Khaldoun Almhanna, Department of Hematology/Oncology, Lifespan Cancer Institute, Providence, RI, USA
  2. Check point inhinitors in the treatment of neuroendocrine tumors
    Jonathan R. Strosberg, Department of GI malignancies, Moffitt Cancer center. Tampa, FL, USA
  3. Immunotherapy and radiation for GI malignancies: Hope or Hype?
    Michael Chuong, Miami Cancer Institute, Miami, FL, USA
  4. Immunotherapy in GI malignancies: what can we learn from other tumors experience?
    Anand Shah, Department of pharmacy. Moffitt Cancer Center, Tampa, FL, USA
  5. Liver cancer and immunotherapy. Where are we and where are we heading?
    Adam Zayac and Khaldoun Almhanna, Lifespan Cancer Institute, Providence, RI, USA
  6. Immunotherapy and pancreatic cancer
    Philip A. Philip, Department of Oncology, Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA
  7. Colon cancer and immunotherapy. Can we go beyond microsatelite instability?
    Rimini Breakstone, Lifespan Cancer Institute, Providence, RI, USA
  8. Esophageal, gastric cancer and immunotherapy: small steps in the right direction?
    Adam Zayac and Khaldoun Almhanna, Lifespan Cancer Institute, Providence, RI, USA
  9. Anal cancer and immunotherapy. Are we there yet?
    Jessica Bian, Lifespan Cancer Institute, Providence, RI, USA
  10. Finding the hot spot: identifying immunosensitive gastrointestinal tumors
    Andre DeSouza, Lifespan Cancer Institute, Providence, RI, USA